× Close
MSF South Africa HIV

South Africa

HIV project in Eshowe reaches 90-90-90 target one year ahead of 2020 deadline

Community Care Giver passes a long queue of patients at Eshowe Gateway Clinic to pick up ARVs ( antiretrovirals) for members of her Community ART ( antiretroviral therapy) Group. KwaZulu-Natal. South Africa. May 2016. © Greg Lomas/MSF
MSF released findings from a follow-up survey of its community-based HIV/TB project in Eshowe, KwaZulu Natal. It shows that the project has achieved the UNAIDS targets of 90-90-90 one year ahead of the 2020 deadline.

    The 90-90-90 targets were set by UNAIDS in 2013 with the aim of scaling up HIV testing and treatment. The targets state that by 2020:

    • 90 % of people living with HIV know their status,
    • 90 % of people who know their HIV-positive status are on antiretroviral therapy,
    • 90 % of people on antiretroviral therapy achieve a viral load that is undetectable.

    The survey ended with the result of 90-94-95, meaning 90% of people living with HIV know their status, 94% of people living with HIV were on antiretroviral treatment and 95% of those had a suppressed viral load. The results support MSF’s view that interventions at community level can successfully reach and directly support more people living with HIV who do not access conventional health services, which is key to getting ahead of the HIV epidemic

    Results show 90-90-90 target is possible

    Along with similar findings from several other HIV population surveys, including two surveys released at SAAIDS ( Southern African AIDS Conference) this week, the MSF results provide strong evidence that achieving the 90-90-90 targets is possible in South Africa, along with hopeful data suggesting that the number of new infections is decreasing in certain areas. The 90-90-90 target is an important indicator of the success of a country’s HIV response, with South Africa’s national results estimated at 85-71-86 (Human Sciences Research Council, 2018).

    We’ve shown that it’s possible to reach 90-90-90 in an area with one of the highest HIV infection rates in the country, where one in four people is living with HIV. These results are testament to the full engagement of the entire community. Everyone - from local civil society and patient groups, health staff and traditional health practitioners, traditional leaders and their members – was deeply involved in designing and helping this project to deliver from the beginning. Importantly, we have ensured 94% of people who tested HIV positive started treatment, including people who are much less likely to test for HIV and link to care, such as men.
    Liesbet Ohler, MSF Project Medical Referent

    Significant improvement in numbers five years on

    The MSF Epicentre population-based survey, which included 3,286 people aged 15 to 59 years, is a follow up to a 2013 survey done by MSF and Epicentre in the same area which was performed to inform priority activities. The 2018 survey found a significant increase in overall HIV status awareness (increased by 14%) and in starting people on treatment (increased by 24%) between 2013 and 2018. Among men, there were striking increases in knowledge of HIV status (first 90), from 68% to 83% and on treatment (second 90), from 68% to 87%.

    Preliminary HIV incidence results (which means the number of new HIV infections) show a trend to decrease, from 1.2% in 2013 to 0.2% in 2018. This is supported by survey findings which show that among the people surveyed, the proportion of those living with HIV who were virally suppressed* increased from 56% (2013) to 84% (2018), signifying a dramatic reduction in the number of people with the potential to transmit HIV.

    Challenges with young women and men remain

    However, MSF cautions against interpreting the survey results as an outright declaration of victory, with significant challenges remaining among specific age groups. “While incidence decreased among women aged 15-29 years from 2.9% to 1.2%, this figure remains high and points to the continued risk faced by adolescent girls and young women,” said Dr Laura Trivino, MSF’s Medical Coordinator for South Africa. “Difficulties remain in reaching men, who overall achieve poorer treatment outcomes across the cascade. More than half of young men aged 15 to 29 years diagnosed with HIV are still not on treatment. We hope these findings will help focus our collective energies on reaching these groups who remain the most vulnerable to HIV.”

    Bending the curves in cooperation with the community

    The ‘Bending the Curves’ project, which started in 2011 before the 90-90-90 targets were set by UNAIDS in 2013, aimed to bend the curves of new HIV infections, and HIV-related illness and death. Numerous activities were launched in partnership with communities and the KwaZulu Natal Department of Health to prevent HIV infection, increase HIV testing, link people quickly to care, and support their adherence, retention and suppression on treatment. 

    Today the project covers ten clinics and two hospitals. Early on, the project invested in community-based prevention and HIV testing strategies, including extensive door-to-door testing by lay workers, with over 120,000 door-to-door tests conducted between 2012 and 2018. Between 2015 and 2018, 1,35 million condoms were distributed annually.

    How did Eshowe get to 90-94-95? I would say it’s the power of partnership. We had the total commitment of the traditional leadership, and close collaboration with the departments of Health and Education at each stage.
    Musa Ndlovu, MSF’s Deputy Field Coordinator in Eshowe

    “In the early days of this project, it was almost impossible for people to even imagine talking about HIV. Today people even stop our MSF vehicles and ask for an HIV test. We didn’t do it for the community, we did it with them,” concludes Musa Ndlovu.


    * Viral suppression means that the antiretroviral treatment is successfully suppressing the amount of HIV virus in a person’s blood, ensuring overall health and greatly reducing the chances of HIV transmission. It was defined as viral load <1,000 copies/mla